Tissue factor-associated neutrophil extracellular traps in dermatomyositis: procoagulant activity and endothelial activation in vitro
Introduction Dermatomyositis (DM) is an immune-mediated myopathy characterized by inflammatory and vascular manifestations and variable systemic involvement; however, the interplay among neutrophil activation, complement, and coagulation remains unclear. We investigated whether serum from patients with DM induces tissue factor (TF)-associated neutrophil extracellular traps (NETs) and examined their functional effects in vitro . Methods Serum from seven patients with active DM and seven matched healthy individuals was analyzed for inflammatory mediators, citrullinated histone H3 (CitH3), thrombin–antithrombin (TAT) complexes, soluble C5b-9, and DNase-I activity. Control neutrophils were exposed to DM serum and, then, NET formation, TF expression and activity, and thrombin generation were assessed. Inhibition experiments targeting complement, TF, and NETs were performed. Co-culture experiments assessed endothelial activation, while skin biopsies were examined by immunofluorescence. Results Patients with DM exhibited increased inflammatory mediators, CitH3, TAT complexes, and soluble C5b-9, together with reduced DNase-I activity. DM serum induced TF expression and release of TF-associated NETs by control neutrophils. DNase-I and eculizumab reduced NET formation, while eculizumab additionally decreased TF mRNA expression and NET-associated TF activity. TF-associated NETs promoted adhesion molecule expression by human aortic endothelial cells, an effect attenuated by DNase-I or TF neutralization. TF-positive NET fragments were detected in lesional DM skin but not healthy skin. Discussion These exploratory findings support a contribution of C5-dependent complement activation to TF-associated NET formation and show that these NETs can enhance thrombin generation and endothelial activation in vitro . Their relationship to clinical vasculopathy or thrombotic risk remains unknown, providing evidence for potential links between inflammation, thrombosis, and vascular injury in DM.
Authors
- Akrivi Chrysanthopoulou (ORCID: https://orcid.org/0000-0002-0325-6146)
- Evangeli S. Lampri (ORCID: https://orcid.org/0000-0002-8633-7135)
- Aliki I. Venetsanopoulou (ORCID: https://orcid.org/0000-0003-4280-9193)
- Paraskevi V. Voulgari (ORCID: https://orcid.org/0000-0002-5193-2284)
- Nikolaos Koletsos (ORCID: https://orcid.org/0000-0001-6976-2802)
- Maria Ntinopoulou (ORCID: https://orcid.org/0009-0001-7558-5133)
- Antigoni Sourla
- Nikolaos Zintziovas (ORCID: https://orcid.org/0009-0000-9528-0583)
- Pavlos Simonopoulos
- Lamprini Efstathiou
Institutions
- University of Ioannina (GR)
- University Hospital of Ioannina (GR)
Publication Details
- Journal
- Frontiers in Immunology
- Published
- 2026-10-30
- DOI
- https://doi.org/10.3389/fimmu.2026.1926259
- Primary Topic
- Neutrophil, Myeloperoxidase and Oxidative Mechanisms
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Hellenic Foundation for Research and Innovation